Top Pharmaceuticals companies in Sweden by EBITDA Margin

This ranking features the top 92 Pharmaceuticals companies in Sweden ranked by EBITDA Margin, averaging a EBITDA Margin of -118.28%, for January 15, 2025.

Sweden

Pharmaceuticals

#	Name	EBITDA Margin	Reported Date	Stock Price	Change	Country
1	OncoZenge AB (publ) 1 ONCOZ.ST	242,200.00%	Dec. 31, 2023	USD 0.45	23.08%	Sweden
2	Linc AB 2 LINC.ST	18,249.32%	Dec. 31, 2023	USD 8.02	0.46%	Sweden
3	Infant Bacterial Therapeutics AB (publ) 3 IBT-B.ST	14,998.70%	Dec. 31, 2023	USD 4.07	-5.72%	Sweden
4	BioArctic AB (publ) 4 BIOA-B.ST	47.94%	Dec. 31, 2023	USD 17.87	3.09%	Sweden
5	Intellego Technologies AB 5 INT.ST	41.43%	Dec. 31, 2023	USD 2.97	0.98%	Sweden
6	Genovis AB (publ.) 6 GENO.ST	40.81%	Dec. 31, 2023	USD 2.09	-2.04%	Sweden
7	RaySearch Laboratories AB (publ) 7 RAY-B.ST	39.71%	Dec. 31, 2023	USD 20.58	0.68%	Sweden
8	BioGaia AB (publ) 8 BIOG-B.ST	38.17%	Dec. 31, 2023	USD 9.75	-0.95%	Sweden
9	Camurus AB (publ) 9 CAMX.ST	32.77%	Dec. 31, 2023	USD 51.72	-0.10%	Sweden
10	Swedish Orphan Biovitrum AB (publ) 10 SOBI.ST	32.70%	Dec. 31, 2023	USD 28.64	0.87%	Sweden
11	ADDvise Group AB (publ) 11 ADDV-B.ST	30.69%	Dec. 31, 2023	USD 0.28	0.36%	Sweden
12	CellaVision AB (publ) 12 CEVI.ST	30.60%	Dec. 31, 2023	USD 18.76	3.89%	Sweden
13	Sleep Cycle AB (publ) 13 SLEEP.ST	27.12%	Dec. 31, 2023	USD 3.33	0.41%	Sweden
14	Lifco AB (publ) 14 LIFCO-B.ST	25.73%	Dec. 31, 2023	USD 28.08	0.23%	Sweden
15	Biotage AB (publ) 15 BIOT.ST	23.20%	Dec. 31, 2023	USD 11.98	-2.51%	Sweden
16	MedCap AB (publ) 16 MCAP.ST	21.54%	Dec. 31, 2023	USD 52.21	-0.68%	Sweden
17	Xvivo Perfusion AB (publ) 17 XVIVO.ST	21.18%	Dec. 31, 2023	USD 42.37	0.78%	Sweden
18	Vimian Group AB (publ) 18 VIMIAN.ST	20.86%	Dec. 31, 2023	USD 3.41	3.24%	Sweden
19	Sectra AB (publ) 19 SECT-B.ST	20.75%	April 30, 2024	USD 22.17	-0.20%	Sweden
20	Swedencare AB (publ) 20 SECARE.ST	20.70%	Dec. 31, 2023	USD 3.87	2.52%	Sweden
21	Serstech AB 21 SERT.ST	20.64%	Dec. 31, 2023	USD 0.12	3.82%	Sweden
22	Stille AB 22 STIL.ST	19.00%	Dec. 31, 2023	USD 19.07	4.08%	Sweden
23	Getinge AB (publ) 23 GETI-B.ST	18.63%	Dec. 31, 2023	USD 16.63	0.49%	Sweden
24	Magle Chemoswed Holding AB (publ) 24 MAGLE.ST	18.43%	Dec. 31, 2023	USD 3.31	2.33%	Sweden
25	Probi AB (publ) 25 PROB.ST	18.42%	Dec. 31, 2023	USD 31.10	0.68%	Sweden
26	Elekta AB (publ) 26 EKTA-B.ST	18.16%	April 30, 2024	USD 5.39	-0.39%	Sweden
27	Arjo AB (publ) 27 ARJO-B.ST	17.86%	Dec. 31, 2023	USD 3.30	3.88%	Sweden
28	AddLife AB (publ) 28 ALIF-B.ST	15.96%	Dec. 31, 2023	USD 12.08	1.50%	Sweden
29	Teqnion AB (publ) 29 TEQ.ST	15.56%	Dec. 31, 2023	USD 14.61	2.17%	Sweden
30	Alzinova AB (publ) 30 ALZ.ST	15.56%	Dec. 31, 2023	USD 0.29	0.68%	Sweden
31	Medicover AB (publ) 31 MCOV-B.ST	14.74%	Dec. 31, 2023	USD 17.18	2.59%	Sweden
32	Essity AB (publ) 32 ESSITY-B.ST	14.21%	Dec. 31, 2023	USD 26.00	1.16%	Sweden
33	Nolato AB (publ) 33 NOLA-B.ST	13.43%	Dec. 31, 2023	USD 4.73	3.81%	Sweden
34	Boule Diagnostics AB (publ) 34 BOUL.ST	11.55%	Dec. 31, 2023	USD 0.89	14.73%	Sweden
35	C-Rad AB (publ) 35 CRAD-B.ST	11.52%	Dec. 31, 2023	USD 2.57	-0.02%	Sweden
36	Mentice AB (publ) 36 MNTC.ST	10.55%	Dec. 31, 2023	USD 2.19	0.18%	Sweden
37	Integrum AB (publ) 37 INTEG-B.ST	8.41%	April 30, 2024	USD 1.60	-0.43%	Sweden
38	Kontigo Care AB (publ) 38 KONT.ST	6.20%	Dec. 31, 2023	USD 0.23	-0.87%	Sweden
39	Bonesupport Holding AB (publ) 39 BONEX.ST	4.90%	Dec. 31, 2023	USD 32.97	-0.61%	Sweden
40	Arcoma AB 40 ARCOMA.ST	3.75%	Dec. 31, 2023	USD 0.97	-2.02%	Sweden
41	Gasporox AB (publ) 41 GPX.ST	3.01%	Dec. 31, 2023	USD 0.78	5.47%	Sweden
42	New Nordic Healthbrands AB (publ) 42 NNH.ST	-0.36%	Dec. 31, 2023	USD 1.35	-1.92%	Sweden
43	Flowscape Technology AB (publ) 43 FLOWS.ST	-0.62%	Dec. 31, 2023	USD 0.28	6.05%	Sweden
44	Orexo AB (publ) 44 ORX.ST	-3.44%	Dec. 31, 2023	USD 1.76	2.86%	Sweden
45	Sprint Bioscience AB (publ) 45 SPRINT.ST	-4.12%	Dec. 31, 2023	USD 0.14	1.34%	Sweden
46	Corline Biomedical AB 46 CLBIO.ST	-6.74%	Dec. 31, 2023	USD 0.84	-0.17%	Sweden
47	Promimic AB (publ) 47 PRO.ST	-9.94%	Dec. 31, 2023	USD 1.88	0.68%	Sweden
48	Ellen AB (publ) 48 ELN.ST	-11.53%	Dec. 31, 2023	USD 0.09	1.68%	Sweden
49	Ortivus AB (publ) 49 ORTI-B.ST	-17.75%	Dec. 31, 2023	USD 0.15	3.82%	Sweden
50	ScandiDos AB (publ) 50 SDOS.ST	-22.10%	April 30, 2024	USD 0.14	0.68%	Sweden

1 2

Frequently Asked Questions

Which Pharmaceuticals company in Sweden has the highest EBITDA Margin ?

The Pharmaceuticals company in Sweden with the highest EBITDA Margin is OncoZenge AB (publ) (Stockholm Stock Exchange: ONCOZ.ST) at 242,200.00%.
Which Pharmaceuticals company in Sweden has the lowest EBITDA Margin ?

The Pharmaceuticals company in Sweden with the lowest EBITDA Margin is Diamyd Medical AB (publ) (Stockholm Stock Exchange: DMYD-B.ST) at -108,995.38%.

What are the top 10 Pharmaceuticals companies in Sweden by EBITDA Margin ?

The top 10 Pharmaceuticals companies in Sweden by EBITDA Margin are OncoZenge AB (publ), Linc AB, Infant Bacterial Therapeutics AB (publ), BioArctic AB (publ), Intellego Technologies AB, Genovis AB (publ.), RaySearch Laboratories AB (publ), BioGaia AB (publ), Camurus AB (publ) and Swedish Orphan Biovitrum AB (publ).
What are the bottom 10 Pharmaceuticals companies in Sweden by EBITDA Margin ?

The bottom 10 Pharmaceuticals companies in Sweden by EBITDA Margin are Diamyd Medical AB (publ), Lipum AB (publ), Qlife Holding AB (publ), SpectraCure AB (publ), Kancera AB (publ), Isofol Medical AB (publ), Nanologica AB (publ), Enorama Pharma AB (publ), IRLAB Therapeutics AB (publ) and Chordate Medical Holding AB (publ).